Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 24

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 24
---
5.

16

AUDIT COMMITTEE REPORT The Board of Directors has reviewed and discussed with management our audited financial statements for the fiscal year ended December 31, 2024, which were audited by Marcum LLP, our independent registered public accounting firm. The Board of Directors discussed with Marcum LLP the matters required to be discussed pursuant to Public Company Accounting Oversight Board (United States) Auditing Standard 1301 (Communication with Audit Committee). The Board of Directors received the written disclosures and letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent registered public accounting firm’s communications with the Board of Directors concerning independence, and discussed with the independent registered public accounting firm the independent registered public accounting firm’s independence. The Board of Directors also considered whether the provision of services other than the audit of our financial statements for the fiscal year ended December 31, 2024 were compatible with maintaining Marcum LLP’s independence. The Board of Directors has selected Marcum LLP as our independent auditor for 2025.

| Respectfully submitted by the audit committee, |
| Messrs. Schroeder, Juda and Allen              |

17

DIRECTORS, OFFICERS AND KEY EMPLOYEES Set forth below are the Company’s Directors, and Executive Officers and key employees as of December 31, 2024, together with an overview of their professional experience and expertise.

| Name                  |     | Age |     | Position(s) Held                                 |     | Director Since |
| Raymond J. Tesi, M.D. |     |  69 |     | President and CEO, and Director                  |     |           2015 |
| David J. Moss         |     |  54 |     | Chief Financial Officer, Treasurer and Secretary |     |            N/A |
| Mark Lowdell, PhD     |     |  62 |     | Chief Scientific Officer                         |     |            N/A |
| J. Kelly Ganjei       |     |  51 |     | Independent Director                             |     |           2016 |
| Timothy Schroeder     |     |  67 |     | Independent Director                             |     |           2016 |
| Scott Juda, J.D.      |     |  54 |     | Independent Director                             |     |           2018 |
| Marcia Allen          |     |  74 |     | Independent Director                             |     |           2019 |

Directors are elected annually and hold office until the next annual